FIRST WAVE BIOPHARMA (FWBI)
US33749P4081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.79M | -14.63M | -58.54M | -32.67M | -15.18M | |||
| Depreciation Amortization | 29.27K | 30.00K | 540.00K | 570.00K | 1.02M | |||
| Change In Working Capital | 2.19M | -10.50M | 17.10M | 14.15M | -1.70M | |||
| Interest Paid | 22.46K | 20.00K | 0.00 | 110.00K | 10.00K | |||
| Taxes Paid | N/A | N/A | 0.00 | N/A | 0.00 | |||
| Other non cash items | 1.20M | 2.76M | 8.61M | 6.73M | 1.83M | |||
| OPERATING CASH FLOW | -12.38M | -22.34M | -32.29M | -11.22M | -14.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -70.00K | 0.00 | -20.00K | |||
| Other Investing Activity | -500.00K | 0.00 | -10.25M | 90.00K | N/A | |||
| INVESTING CASH FLOW | -500.00K | 0.00 | -10.32M | 90.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -603.49K | -640.00K | 90.00K | 2.86M | 3.61M | |||
| Stock Issued/Repurchased | 15.83M | 23.30M | 44.67M | 14.19M | 9.54M | |||
| Other Financing Activity | N/A | -6.91M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 15.23M | 15.74M | 44.76M | 17.05M | 13.14M | |||
| Exchange Rate Effect | N/A | -260.00K | 30.00K | -30.00K | -30.00K | |||
| CHANGE IN CASH | 2.35M | -6.86M | 2.18M | 5.89M | -940.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.38M | -22.34M | -32.29M | -11.22M | -14.03M | |||
| Capital Expenditure | N/A | 0.00 | -70.00K | 0.00 | -20.00K | |||
| FREE CASH FLOW | -12.38M | -22.34M | -32.36M | -11.22M | -14.05M | |||
All data in USD